Home

Clinical Research in India

Home
  • Home
  • About Us
  • Message Board

isi emerging markets

Siro could be a booster for Biocon - ISI - Emerging Markets (subscription)

  • biocon
  • buzz
  • clinical research organisation
  • isi emerging markets

Siro could be a booster for BioconISI - Emerging Markets (subscription)Biocon will have much to gain from a possible alliance with clinical research organisation Siro Clinpharm. There is a buzz in the markets that the ...and more »

Japanese Pharma cos see big opportunities in India - ISI - Emerging Markets

  • attractive environment
  • bad reputation
  • clinical research
  • india
  • isi emerging markets
  • medicines
  • news articles
  • pharma cos

Japanese Pharma cos see big opportunities in IndiaISI - Emerging MarketsMr Toda said India was strong in IT and attractive environment for clinical research, while its weakness lay in “bad reputation” on quality of medicines and ...India to maintain edge in genericsBusiness Standardall 2 news articles »

IFCR plans to enter healthcare sector - ISI - Emerging Markets

  • clinical research institute
  • healthcare sector
  • healthcare services
  • india
  • isi emerging markets
  • kochi
  • mba in healthcare
  • services management

IFCR plans to enter healthcare sectorISI - Emerging Markets, New YorkKochi, June 5: IFCR India, a clinical research institute in the State, is all set to enter the healthcare sector with various projects. The institute will also launch an advanced MBA in healthcare services management in August. ...

RoopleTheme